Dong N. Ying

State Key Laboratory Of Vaccines For Infectious Diseases
Xiamen, 361102, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Broad neutralizing antibody response of a monomeric spike-based SARS-CoV-2 bivalent vaccine against diverse variants.

Broad neutralizing antibody response of a monomeric spike-based SARS-CoV-2 bivalent vaccine against diverse variants.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 25, 2025

Nanobody-based combination vaccine using licensed protein nanoparticles protects animals against respiratory and viral infections.

Nanobody-based combination vaccine using licensed protein nanoparticles protects animals against respiratory and viral infections.

Journal: Nature biomedical engineering

Published: May 02, 2025

The crucial but insufficient role of E2s domain's residues 490 and 492 in determining the host tropism of hepatitis E virus.

The crucial but insufficient role of E2s domain's residues 490 and 492 in determining the host tropism of hepatitis E virus.

Journal: Nature communications

Published: February 19, 2025

Structural basis for the synergetic neutralization of hepatitis E virus by antibody-antibody interaction.

Structural basis for the synergetic neutralization of hepatitis E virus by antibody-antibody interaction.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 25, 2024

Cell binding tropism of rat hepatitis E virus is a pivotal determinant of its zoonotic transmission to humans.

Cell binding tropism of rat hepatitis E virus is a pivotal determinant of its zoonotic transmission to humans.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 28, 2024

Antibodies elicited by hepatitis E vaccination in humans confer cross-genus protection against rat hepatitis E virus.

Antibodies elicited by hepatitis E vaccination in humans confer cross-genus protection against rat hepatitis E virus.

Journal: Journal of hepatology

Published: October 19, 2024

Substantial spillover burden of rat hepatitis E virus in humans.

Substantial spillover burden of rat hepatitis E virus in humans.

Journal: Nature communications

Published: July 22, 2024

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)

Published: July 21, 2023

Transcriptome Profiling of Male Adult Angiostrongylus cantonensis.

Transcriptome Profiling of Male Adult Angiostrongylus cantonensis.

Journal: Iranian journal of parasitology

Published: March 20, 2023

Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency.

Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency.

Journal: Frontiers in immunology

Published: March 10, 2023

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study.

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study.

Journal: Emerging microbes & infections

Published: October 31, 2022

A Secreted Form of the Hepatitis E Virus ORF2 Protein: Design Strategy, Antigenicity and Immunogenicity.

A Secreted Form of the Hepatitis E Virus ORF2 Protein: Design Strategy, Antigenicity and Immunogenicity.

Journal: Viruses

Published: August 15, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026